CTN(SZ:300430)2022-12-07 08:24Group 1: Company Leadership - Chairman Liang Xuexian, aged 75, remains active and engaged in company operations and market changes, demonstrating a commitment to ongoing development [1][2] - General Manager Liang Kai, aged 46, has 17 years of experience leading the company, indicating strong management capabilities and a determination to drive future growth [2] Group 2: Management Team Characteristics - The management team consists entirely of technical personnel, with a strong focus on research and market sales, highlighting their deep understanding of the company's main products [2] - Capital operations are identified as a new area for learning and development within the team [2] Group 3: Future Development Directions - The company aims to continue developing around its core business, particularly in the pharmaceutical and biotechnology sectors, indicating untapped opportunities [3] - The focus is on providing better services and leveraging capital market strengths to enhance company growth [3] Group 4: Industry Trends - The concept of Industry 4.0 is recognized as a significant trend, with an emphasis on the integration of digitalization and intelligence in manufacturing processes [3] - The transition to automated and intelligent production requires time and a shift in client perspectives, supported by government initiatives to accelerate this process [3]